CAT No: AAD-438
CAS No:38837-70-6
Synonyms/Alias:38837-70-6;gamma-Glutamyl-valyl-glycine;(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid;gamma-Glu-Val-Gly;glutamyl-valyl-glycine;L-gamma-Glutamyl-L-valylglycine;L-gamma-glutamyl-L-valyl-glycine;kokumi peptide;|A-Glu-Val-Gly;gamma-glutamyl-valinyl-glycine;SCHEMBL14892877;CHEBI:195377;HJXBLWNEFLKSSL-XVKPBYJWSA-N;DTXSID001019393;MFCD28411851;HY-W614632;F77378;(2S)-2-AMINO-4-{[(1S)-1-(CARBOXYMETHYLCARBAMOYL)-2-METHYLPROPYL]CARBAMOYL}BUTANOIC ACID;(2S)-2-amino-5-[[(2S)-1-(carboxymethylamino)-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid;(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoicacid;
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.